Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

argenx to acquire Forte Biosciences for $2.2 billion

PRIVATEJul 27, 2026•13 days ago

Acquiring Company

argenx

Acquired Company

Forte Biosciences

AmsterdamBiotechnologyHealth CareTherapeutics

Description

argenx has announced its acquisition of Forte Biosciences for $77 per share, totaling approximately $2.2 billion. This acquisition aims to integrate Forte's lead program, FB102, into argenx's immunology portfolio. The deal highlights argenx's commitment to advancing innovative immunology treatments.

Company Information

Company

argenx

Location

Amsterdam, North Holland, Netherlands

About

argenx is a global immunology innovation company focused on developing therapies for patients with severe autoimmune diseases. The company specializes in antibody-based therapies and has a strong portfolio aimed at improving patient outcomes. With a commitment to scientific excellence, argenx aims to lead the field of immunology.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for argenx's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.